The zero static diaphragm valve market is projected to grow from USD 1.3 billion in 2026 to USD 2.8 billion by 2036, at a CAGR of 7.8%. Zero static diaphragm valves will dominate with a 46.0% market share, while pharmaceutical and biotech will lead the end‑use industry segment with a 44.0% share.